Clinical Evidence

Prevention of Atopic Dermatitis in High-Risk Infants

Growing evidence highlights the role of physiological lipids in maintaining skin barrier function and preventing atopic dermatitis (AD). Prevention of Atopic Dermatitis in High-Risk Infants: A Review of the Role of Lipid-Based Barrier Repair Therapy discusses how lipid-based therapies can replenish deficient skin lipids, improving barrier function.

SmartLipids in Drug Delivery

SmartLipids represent a new generation of lipid-based nanocarriers that enhance drug delivery and formulation science. They offer high encapsulation efficiency and improved bioavailability, as detailed in SmartLipids in Drug Delivery: Redefining the Third Generation of Lipid Nanocarriers for Clinical and Industrial Translation.

Basic Emollients for Xerosis Cutis

Topical emollients, including those with Caprylic/Capric Triglyceride, restore skin hydration and barrier function, crucial for managing xerosis cutis in AD. This is supported by findings in Basic Emollients for Xerosis Cutis in Atopic Dermatitis: A Review of Clinical Studies.